OPUBS
Organization of Pharmaceutical Unity with BioAllied Sciences (OPUBS) is an educational society registered under “The Societies Registration Act, 1860” with Govt. of India.
The association has been made to bring along the people from different spheres of Pharmaceutical and bio-allied sciences so as to give them a common platform to express their ideas and to move along in a well directed manner. This association includes all different branches like pharmaceutical sciences, analytical/medicinal chemistry, biotechnology, medical sciences, biomedical sciences and other allied sciences.
OUR MISSION
- To provide a platform and collaboration to interact, exchange information and ideas on different fields of pharmaceutical and bio-allied sciences to give new heights to bio research and education.
- To provide a forum for exchange thoughts on social, economic and educational ideas.
- Provides training to students to become “Master Students”.
Projected Impact factor of JPBS : 0.175
On Medknow websie, we can check the projected impact factor of JPBS : 0.175.
For official impact factor, we need some more time…
www.jpbsonline.org
Changes in 2011…
Acquisition Gives Wolters Kluwer Health Strong Foothold in Open Access Publishing Business
Philadelphia, PA (December 5, 2011) – Wolters Kluwer Health today announced that it has acquired Medknow Publications & Media Pvt. Ltd., a leading Scientific, Technical & Medical (STM) journal publishing operation headquartered in Mumbai, India and one of the largest open access publishers in the world. The acquisition expands Wolters Kluwer Health’s Medical Research business’ presence in key developing markets and supports its strategy to increase locally written content and incorporate more open access platforms into its business model. Terms of the deal were not disclosed.
Original research article and Critical reviews are invited for publication in www.jpbsonline.org and www.cysonline.org
JPBS- Facebook page launched..click on Like
Click on the page to Like it…
Chronicles of Young Scientists – Page launched
Click on the link..then click on LIKE…
Click on this Page to LIKE it…
PharmaShine – 2011, results announced
PharmaShine – 2011, which is organised by OPUBS and PharmaTutor, announces the results
Despite of Top 3 articles which will be publish in CYS-International Journal, we decide that not only three but other articles which are near to the winners, will also publish in CYS as merit award after peer review.
So Top 3 are:
No. 1 : PHARMATUTOR-ART-1073
Ankit Parikh
Novel Targeted drug delivery systems – new age weapons for bladder diseases
Pharmaceutics
No. 2 : PHARMATUTOR-ART-1070
Pramod Kumar
MAGNETIC PARTICLES FOR DRUG DELIVERY: AN OVERVIEW
Pharmaceutics
No. 3 : ART-1063
Tapan Behl
Alternatives to Animal Testing: A Vantage Over Animal Models
Pharmacology
Merit Awards goes to:
1. ART-1023
Komal R. Nikam
RECENT TRENDS IN INSULIN DRUG DELIVERY SYSTEM
Pharmacology
2. ART-1032
Thota Venkatesh
PHARMACOLOGICAL SCREENING OF ANTIINFLAMMATORY ACTIVITY OF KSHEERABALA THAILAM
Pharmacology
3. ART-1036
Amit Surani
CHALLENGES IN IMPLEMENTATION OF PROCESS ANALYTICAL TECHNOLOGY (PAT) – A REVIEW
Pharmaceutics, Pha.Analysis
4. ART-1037
Arun Kumar Dash
Study of Antimicrobial Property of Some hypoglycemic Drugs
Pharmacology
5. ART-1055
Rajyalaxmi Dhulipathi
Formulation and evaluation of floating microspheres of metformin hydrochloride
Pharmaceutics
6. ART-1060
Chetan matholiya
PULSATILE DRUG DELIVERY SYSTEM: A REVIEW
Pharmacology
7. ART-1065
Rajan Sharma Bhattarai
Drug Delivery using Alginate and chitosan beads: An Overview
Pharmaceutics
8. ART-1068
Niroj Shreshtha
Transdermal Drug Delivery System: An Overview
Pharmaceutics
9. ART-1072
Anjali Gujera
Buccal Delivery System
Pharmaceutics
10. ART-1074
Akansha Patel
EMERGING APPLICATIONS OF GOLD NANOPARTICLES IN FIELD OF DRUG AND GENE DELIVERY
Pharmaceutics
Journal of Pharmacy & BioAllied Sciences (JPBS) April-June 2011 issue is now online..
www.jpbsonline.org
New Technology Fuses MRI, Ultrasound to Achieve Targeted Biopsy of Prostate Cancer http://ping.fm/LYzJT
Roche submits NDA in US and Europe for vemurafenib in advanced skin cancer http://ping.fm/gUCjs


